☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
tuberculosis
BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022
July 27, 2021
Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis
February 28, 2020
GSK Out Licenses its Tuberculosis Vaccine (M72/AS01E ) to Bill & Melinda Gates Medical Research Institute
January 28, 2020
BioNTech Signs an Agreement with Gates Foundation to Develop Therapies for HIV and Tuberculosis
September 5, 2019
TB Alliance's Pretomanid Combination Therapy Receives the US FDA's Approval for Highly Drug-Resistant Forms of Tuberculosis
August 15, 2019
Roche Launches Cobas MTB-RIF/INH Test for the Detection of Antimicrobial Resistance in Tuberculosis
May 14, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.